BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33267867)

  • 21. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection.
    Moon PG; Lee JE; Cho YE; Lee SJ; Jung JH; Chae YS; Bae HI; Kim YB; Kim IS; Park HY; Baek MC
    Clin Cancer Res; 2016 Apr; 22(7):1757-66. PubMed ID: 26603257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
    Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
    BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Strategy to Investigate Tissue-Secreted Tumor Microenvironmental Proteins in Serum toward Development of Breast Cancer Early Diagnosis Biomarker Signature.
    Pendharkar N; Dhali S; Abhang S
    Proteomics Clin Appl; 2019 May; 13(3):e1700119. PubMed ID: 30281209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
    Evans RL; Pottala JV; Egland KA
    Cancer Prev Res (Phila); 2014 May; 7(5):545-55. PubMed ID: 24641868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
    Sharma SD; Barry M; O'Reilly EA; Kell MR
    Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.
    Pitteri SJ; Amon LM; Busald Buson T; Zhang Y; Johnson MM; Chin A; Kennedy J; Wong CH; Zhang Q; Wang H; Lampe PD; Prentice RL; McIntosh MW; Hanash SM; Li CI
    Cancer Res; 2010 Nov; 70(21):8598-606. PubMed ID: 20959476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative analysis of early diagnostic tools for breast cancer].
    Shen SJ; Sun Q; Xu YL; Zhou YD; Guan JH; Mao F; Lin Y; Wang XJ; Han SM
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):877-80. PubMed ID: 23291142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.
    Lee J; Jung JH; Kim WW; Park CS; Lee RK; Kim HJ; Kim WH; Park HY
    BMC Cancer; 2020 Sep; 20(1):934. PubMed ID: 32993586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk.
    Iwase M; Tsunoda H; Nakayama K; Morishita E; Hayashi N; Suzuki K; Yamauchi H
    Breast Cancer; 2017 Jul; 24(4):579-584. PubMed ID: 27873170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia.
    Papantoniou V; Valsamaki P; Sotiropoulou E; Tsaroucha A; Tsiouris S; Sotiropoulou M; Marinopoulos S; Kounadi E; Karianos T; Fothiadaki A; Archontaki A; Syrgiannis K; Ptohis N; Makris N; Limouris G; Antsaklis A
    Mol Imaging; 2011 Oct; 10(5):370-6. PubMed ID: 21521552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
    Swellam M; El Magdoub HM; Hassan NM; Hefny MM; Sobeih ME
    Clin Biochem; 2018 Jun; 56():47-54. PubMed ID: 29679553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Impacting False Positive Recall in Screening Mammography.
    Honig EL; Mullen LA; Amir T; Alvin MD; Jones MK; Ambinder EB; Falomo ET; Harvey SC
    Acad Radiol; 2019 Nov; 26(11):1505-1512. PubMed ID: 30772138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
    Lourenco AP; Benson KL; Henderson MC; Silver M; Letsios E; Tran Q; Gordon KJ; Borman S; Corn C; Mulpuri R; Smith W; Alpers J; Costantini C; Rohatgi N; Yang R; Haythem A; Biren S; Morris M; Kass F; Reese DE
    Clin Breast Cancer; 2017 Nov; 17(7):516-525.e6. PubMed ID: 28624156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A plasma metabolite panel as biomarkers for early primary breast cancer detection.
    Yuan B; Schafferer S; Tang Q; Scheffler M; Nees J; Heil J; Schott S; Golatta M; Wallwiener M; Sohn C; Koal T; Wolf B; Schneeweiß A; Burwinkel B
    Int J Cancer; 2019 Jun; 144(11):2833-2842. PubMed ID: 30426507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.